2025
SJR Q2
JCR Q3 · 2,1
OA
ESCI
Journal detail
AIDS Research and Treatment
- Publisher
- John Wiley and Sons Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
2090124020901259
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,652
- Quartile Q2
- H-Index 37
- Cites/doc 2,06
- Docs (3y) 29
- Cites (3y) 60
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,1
- 5Y JIF 2,3
- JCI 0,42
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Dermatology Q2
- Immunology and Allergy Q3
- Infectious Diseases Q2
- Public Health, Environmental and Occupational Health Q2
Areas
- Medicine
WoS categories
- Infectious Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,652 | 2,1 | 2,3 | 0,42 | Q3 | 37 |
| 2024 | Q2 | Q3 | 0,591 | 1,8 | 2,2 | 0,39 | Q4 | 35 |
| 2023 | Q2 | Q4 | 0,566 | 1,1 | 1,5 | 0,25 | Q4 | 35 |
| 2022 | Q2 | — | 0,567 | 1,7 | 2,3 | 0,4 | Q3 | 35 |
| 2021 | Q2 | — | 0,511 | — | — | 0,34 | Q4 | 35 |
| 2020 | Q2 | — | 0,749 | — | — | 0,4 | Q4 | 35 |
| 2019 | Q1 | — | 0,882 | — | — | — | — | 35 |
| 2017 | Q2 | — | 0,758 | — | — | — | — | 35 |
| 2016 | Q1 | — | 0,805 | — | — | — | — | 35 |
| 2015 | Q1 | — | 1,133 | — | — | — | — | 35 |
| 2014 | Q1 | — | 1,163 | — | — | — | — | 35 |
| 2013 | Q1 | — | 0,949 | — | — | — | — | 35 |
| 2012 | Q1 | — | 1,012 | — | — | — | — | 35 |
| 2011 | Q2 | — | 0,401 | — | — | — | — | 35 |
| 2010 | — | — | — | — | — | — | — | 35 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | INFECTIOUS DISEASES | ESCI | Q3 | Q3 | 95/141 |
| 2024 | INFECTIOUS DISEASES | ESCI | Q3 | Q4 | 95/137 |
| 2023 | INFECTIOUS DISEASES | ESCI | Q4 | Q4 | 114/132 |
| 2022 | INFECTIOUS DISEASES | ESCI | — | Q3 | — |
| 2021 | INFECTIOUS DISEASES | ESCI | — | Q4 | — |
| 2020 | INFECTIOUS DISEASES | ESCI | — | Q4 | — |